Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on the NYSE and NASDAQ

Here is a table of 7 cannabis stocks that are developing cannabis compound medicines.

7 Cannabis Pharma Stocks

Stock Returns & Price Chart


Recent Prices &
Annualized Return

Arena PharmaceuticalsARNA
Cara TherapeuticsCARA
Corbus Pharmaceuticals HoldingsCRBP
GW PharmaceuticalsGWPH
INSYS TherapeuticsINSY
Zynerba PharmaceuticalsZYNE
Price data from Quandl as of most recent close.

To inspect the performance of the Cannabis Pharma Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

All 7 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.

The current value of a $10,000 investment is $9,401. The percent return is -5.99%. The annualized return is -2.71%.

Return Summary for Cannabis Pharma Stocks
Start DateSep-29-2017
Start Investment$10,000.00
End DateDec-06-2019
Current Value of Investment$9,401.33
Total Return-5.99%
Annualized Return-2.71%
Min DateDec-31-2018
Min Price$8,220.34
Max DateJun-28-2019
Max Price$12,951.80
# Values28
Number Returns378
Number Profitable Returns217
Percent Profitable Returns57.41%
Number Unprofitable Returns161
Percent Unprofitable Returns42.59%
Profitable to Unprofitable Returns Ratio1.35

NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.

See Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on OTC Markets.

Related Portfolios

Database with Comments of Marijuana (Cannabis) Stocks (A-Z)

Portfolio of Marijuana (Cannabis) Growers Stocks Traded on the NYSE and NASDAQ

Portfolio of Marijuana (Cannabis) Stocks

Portfolio of Marijuana (Cannabis) Stocks Traded on OTC Markets